Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Viavi Solutions Inc

Viavi Solutions Inc

VIAV

0.00

  • Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.
  • This upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform spanning 6G FR3, Wi‑Fi 7/8, aerospace, defense and Integrated Sensing and Communication applications.
  • Next, we’ll examine how Vertex 6.0’s 6G- and Wi‑Fi 7-ready channel emulation could influence Viavi Solutions’ long-term investment narrative.

The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Viavi Solutions Investment Narrative Recap

To own Viavi Solutions, you need to believe its test and measurement portfolio can convert 6G, Wi Fi 7/8 and AI networking transitions into durable, profitable growth, despite recent losses and cyclicality in service provider spending. Vertex 6.0 appears supportive of that thesis in the near term, but it does not immediately change the key swing factors: how quickly wireless test demand recovers and whether Viavi can integrate Spirent’s assets without margin or leverage setbacks.

Among recent announcements, the June launch of Viavi’s Ultra Ethernet Transport validation for AI fabrics is particularly relevant, because it highlights how the company is tying high performance data center test and emerging 6G channel emulation together. If both AI data center build outs and advanced wireless testing hold up, they could collectively help offset weakness in traditional service provider and cable spending and reduce earnings volatility tied to operator budgets.

Yet, against the promise of Vertex 6.0, investors should still be aware of how much depends on successful Spirent integration and the risks if those expected benefits...

Viavi Solutions’ narrative projects $2.5 billion revenue and $503.0 million earnings by 2029. This requires 18.0% yearly revenue growth and a $533.4 million earnings increase from -$30.4 million today.

Uncover how Viavi Solutions' forecasts yield a $61.43 fair value, a 58% upside to its current price.

Exploring Other Perspectives

VIAV 1-Year Stock Price Chart
VIAV 1-Year Stock Price Chart

Some of the most optimistic analysts were already assuming Viavi could reach about US$2.7 billion of revenue and US$1.1 billion of earnings by 2029, which is far more aggressive than consensus. Vertex 6.0 and the broader 6G test opportunity might reinforce that view or expose how much it depends on uninterrupted AI data center spending and flawless acquisition execution, so it is worth comparing these bullish expectations with more cautious scenarios before deciding which story you find more convincing.

Explore 4 other fair value estimates on Viavi Solutions - why the stock might be worth 28% less than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Viavi Solutions research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Viavi Solutions research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Viavi Solutions' overall financial health at a glance.

Curious About Other Options?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

  • Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.